Back
Health Catalyst 10K Form
Sell
50
HCAT
Health Catalyst
Last Price:
$4.11
Seasonality Move:
1.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HCAT News And Ratings
See the #1 stock for the next 7 days that we like better than HCAT
HCAT Financial Statistics
Sales & Book Value
| Annual Sales: | $306.6M |
|---|---|
| Cash Flow: | $-5.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.41 |
| Price / Book: | 0.76 |
Profitability
| EPS (TTM): | -1.15000 |
|---|---|
| Net Income (TTM): | $-72.7M |
| Gross Margin: | $140.8M |
| Return on Equity: | -20.06% |
| Return on Assets: | -9.2% |
Health Catalyst Earnings Forecast
Key Health Catalyst Financial Ratios
-
The Gross Profit Margin over the past 8 years for HCAT is 45.92%.
-
The Selling, General & Administrative Expenses for HCAT have been equal to 36.27% of Gross Profit Margin.
-
The Research & Development expenses have been 18.90% of Revenue.
-
The Net Earning history of HCAT is -22.67% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 4 years.
Health Catalyst Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | HCAT |
| CUSIP: | 42225T |
| Website: | healthcatalyst.com |
Debt
| Debt-to-Equity Ratio: | 1.02 |
|---|---|
| Current Ratio: | 1.24 |
| Quick Ratio: | 1.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 10.49 |
HCAT Technical Analysis vs Fundamental Analysis
Sell
50
Health Catalyst (HCAT)
is a Sell
Is Health Catalyst a Buy or a Sell?
-
Health Catalyst stock is rated a SellThe current Health Catalyst [HCAT] share price is $4.10. The Score for HCAT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.